Liver Cancer Care

Earlier this year, Pfizer, Eli Lilly, and Merck agreed to create a nonprofit Asian Cancer Research Group to support their anti-cancer drug research.  The ACRG has a data bank based on a 2,000 lung and gastric cancer specimen biorepository.  Related to this, Pfizer, as part of its $300m R&D commitment to South Korea, has undertaken a liver cancer biorepository with the Samsung Medical Center in Seoul.  Why so much activity in Asia?-wider genetic diversity (which is a function of population size over time), greater ease in collecting tissue, lower R&D costs; and Asian governments’ aim of achieving world leadership in biotechnology and translational medicine.             MORE

Image Credit: Sebastian Kaulitzki – Fotolia.com and Genetic Engineering and Biotechnology News